Pricing Log in Create free account

Legend Biotech Corporation Sponsored ADR (LEGN) vs Telix Pharmaceuticals Limited (TLX)

Legend Biotech Corporation Sponsored ADR and Telix Pharmaceuticals Limited are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR and Telix Pharmaceuticals Limited are of similar size ($3.8B and $3.6B). Across the 9 metrics below, Telix Pharmaceuticals Limited leads on 5 and Legend Biotech Corporation Sponsored ADR on 4.

Valuation

Metric LEGN TLX Biotechnology median
P/E n/m — 8.50
P/S 2.72 — 9.71
P/B 2.81 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.22 n/m 9.21
Earnings yield (2.68%) — (33.15%)
Free cash flow yield (3.54%) 0.00% (25.50%)

Profitability

Metric LEGN TLX Biotechnology median
Gross margin 56.58% — 65.16%
Operating margin (5.06%) — 0.00%
Net margin (7.20%) — 0.00%
Free cash flow margin (9.58%) 0.00% 0.00%
Return on equity (8.08%) 0.00% (56.36%)
Return on assets (5.32%) 0.00% (48.04%)
Return on invested capital (9.54%) 0.00% 0.00%

Growth

Metric LEGN TLX Biotechnology median
Revenue growth (TTM) 59.55% — 6.02%
EPS growth (last fiscal year) (66.34%) (120.00%) 30.26%
Revenue growth, 5-year CAGR 65.93% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LEGN TLX Biotechnology median
Debt to equity 0.13 1.18 0.00
Current ratio 3.04 2.01 4.72
Net debt to EBITDA 2.31 6.25 0.96

Dividend

Metric LEGN TLX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LEGN TLX Biotechnology median
Market cap 3.84b 3.60b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack